You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
希瑪眼科(03309.HK):希瑪投資完成認購Avalon Global 5%股份
格隆匯 01-31 19:15

格隆匯1月31日丨希瑪眼科(03309.HK)公告,內容有關(其中包括)涉及認購Avalon Global認購股份的股份交易(涉及根據一般授權發行代價股份)。

董事會欣然宣佈,認購協議所載的所有先決條件均已獲達成,故截止已於2020年1月31日進行,據此,(i)希瑪投資已認購,及Avalon Global已向希瑪投資配發及發行認購股份(相當於Avalon Global經配發及發行認購股份擴大後的已發行股本約5%);(ii)386.43萬股新股份已由公司根據一般授權按照認購協議的條款及條件以每股代價股份5.03港元的代價股份價格配發及發行予Avalon Bio Medical(Management)Limited(即AvalonGlobal的代名人及間接全資附屬公司);及(iii)希瑪投資已訂立股東協議。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account